Vimian Group
Vimian Group AB is a Swedish animal health company providing specialized veterinary products and services globally. The company manages four business segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. Its product portfolio encompasses allergy diagnostics, specialty pharmaceuticals, orthopedic implants, surgical instrumentation, and veterinary practice software. Primary revenue drivers are direct equipment and consumable sales to veterinary clinics, specialty animal hospitals, and laboratories across North America and Europe. Vimian Group holds a leading market position within specialized global veterinary healthcare niches. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq First North Premier Growth Market.
18 of the funds FundTelligence covers report a position in Vimian Group.
- Legal name
- Vimian Group AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 18
Funds holding Vimian Group
- Case All Star Småbolag — Case · 3.87 % (full portfolio disclosed, June 2026)
- Storebrand High Yield Företagsobligation — Storebrand · 1.96 % (full portfolio disclosed, October 2026)
- Nordea Innovation Sustainable Stars — Nordea Funds · 1.91 % (full portfolio disclosed, June 2026)
- Ruth Core Nordic Credit — Ruth · 1.79 % (largest positions only, September 2026)
- DNB Fund Nordic Small Cap — DNB · 1.55 % (full portfolio disclosed, September 2026)
- Spiltan Högräntefond — Spiltan Fonder · 1.49 % (full portfolio disclosed, June 2026)
- SEB Sverigefond Småbolag — SEB · 1.41 % (full portfolio disclosed, June 2026)
- Danske Invest Nordisk Kredittobligasjon — Danske Invest · 0.76 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 18 funds holding it.